Delivery Order SPE2DB22D2206-SPE2DB25FJL45
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,398.12, is for the supply of 4566821134 Hydralazine 20 mg/ml vials. It is a firm fixed-price, delivery order contract with a completion date of January 3, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,174.24 by the Defense Logistics Agency Medical Supply Chain on August 11, 2025, for the supply of Hydralazine Hydrochloride. This firm fixed-price, competitively awarded contract is scheduled for completion by September 8, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract issued under a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,487.22 firm-fixed-price delivery order is for the supply of HYDRALAZINE 20 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of July 14, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency awarded a $25,635.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 tablets of 10 mg hydralazine. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance is from August 29, 2023 through August 30, 2023. As the DLA supports the medical readiness of the U.S. military, this delivery order was likely placed to replenish pharmaceutical inventory for DLA-managed military...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $4,523.05 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561895024 units of Hydralazine 20 mg/ml vials. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 22 to August 23, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces by procuring...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,023.20 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that allows AmerisourceBergen to deliver a comprehensive range of pharmaceuticals and medical supplies to military treatment programs and facilities...
- The Defense Logistics Agency awarded a $91,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 bottles of 12.5 mg hydrochlorothiazide tablets. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the products from its facility in Conshohocken, Pennsylvania under a one-day period of performance concluding on September 19, 2023. The award was issued utilizing an existing DLA pharmaceutical supply vehicle and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 12.5 mg hydrochlorothiazide tablets. The $3,426.72 delivery order has a completion date of February 21, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this order, which is placed under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,348.21 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100-count supply) with a completion date of July 28, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJL45Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,484.37 to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This delivery order exemplifies AmerisourceBergen's comprehensive role in supplying pharmaceutical products across the Defense Health Agency and federal healthcare systems. Hydralazine, a vasodilator used in the treatment of hypertension, will be delivered to the Conshohocken, Pennsylvania location. The award reflects the company's demonstrated capability to fulfill federal medical supply requirements through open competition, consistent with its portfolio of competitively awarded delivery orders ranging from minimal to substantial values. AmerisourceBergen's SPE2DX IDC serves as a flexible global pharmaceutical support vehicle enabling the distribution of specialty medications, generic drugs, vaccines, and related medical supplies to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 8/15/25 |